#Tumor

c0nc0rdance

c0nc0rdance

Hi Matthew, I'm a cancer biologist, and we use the evolutionary model every day to understand cancer progression at the cellular level.Inherited changes in tumor cells produce populations that diversify

Nik Joshi

Joshilabyale

I’m excited to announce that our paper showing how tumor draining lymph nodes contain a long-term, stable reservoir of anti-tumor CD8 T cells is now online at @biorxiv. This is

Nik Joshi

Joshilabyale

A tweetorial on our recent pre-print. This work started with a basic question about what B cells and T follicular T cells do in lung cancer. We and others saw

brendan

brendan_49

The rationale for ROR1 as CAR-T target:1) Expression restricted to fetus and tumors. If ADC's are safe CARs should be too.2) ADCs nabbed monotherapy CRs in MCL.3) Diverse tumors evolve

Amy Wisdom

AmyWisdom8

Excited to share that our paper is out today in @NatureComms https://www.nature.com/articles/s41467-020-19917-0. A great collaboration from @DKirschMDPhD @YvonneMowery @DukeRadOnc @DukeCancer and @Barzin_@max_diehn @StanfordCancer examining

Brian Cox, MD, MAS

Dr_Brian_Cox

Name the following tumor of neural crest origin: Is this a: Paraganglioma...showing the nested "zellballen" growth pattern with vascularized fibrous stroma. We use synapto/chromo/CD56 to highlight tumor cells. Sustentacular cells

Karen Pinto DNB, FRCPath

TheKarenPinto

A #PathQuiz on the #CAPProtocol of cancers of the anus#pathology #GIPath1. According to WHO, squamous cell carcinoma (SCC) of the anus should be subtyped as: large cell keratinizing, large cell

Roxy Striar

roxystriar

THIS THREAD IS WORTH YOUR TIME & MEANS THE WORLD TO ME:Today is #GBMDay — the 2nd annual Glioblastoma Awareness Day. Glioblastoma is an extremely aggressive type of brain cancer

The Pittet Lab

PittetLab

Happy to share our latest work on tumor-infiltrating dendritic cells (DC)! https://doi.org/10.1084/jem.20200264 We know these cells can play key antitumor functions, but they require more attention and could become important

Pharm. D

Pharmdca

$MREO Thread1)Focus of this thread: Etigilimab and AlvelestatFinancials: Roughly $200 million in cash (50M from upfront payment from Ultragenyx & $115M raise from a strong secondary last week). Company fully

Patrik Simmler

PatrikSimmler

I am happy to share our preprint about the #splicing factor SF3B1 that contributes to tumor malignancy by facilitating the adaption to hypoxia in solid cancers. SF3B1 interacts with #HIF1α

Sri Krishna

tellkrish

With @franklowery our new study on attributes of T cells that contribute to successful cell therapy in cancer patients in @ScienceMagazine today w/ colleagues @slgoff_SB, @NCI_CCR_SB @theNCI a TL;DR thread

Sandip Patel MD

PatelOncology

KEYNOTE-158 study out in Lancet Oncology, Pembrolizumab for TMB>10- most data time date we have seen since FDA approval, key aspects include tumor types studiedhttps://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(20)30445-9/fu

Simon Barnett

sbarnettARK

Let's discuss a key aspect of vertical integration for diagnostics companies involved in #oncology testing:Synthetic Biology (#SynBio) We think maximum operating leverage will accrue to those companies who have bought,

Ryan Reeves

investing_city

Genomics Thread #6Let's talk about liquid biopsies... 1/ A liquid biopsy is usually a blood-based test that can detect cancer. How?By detecting either CTC (circulating tumor cells) or ctDNA (circulating

Simon Johnston

cancerdocsi

Lobular disease accounts for more than 1 in 10 cases of breast cancer. It is often referred to as the sneaky subtype because it can evade detection. A lot has

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.